WaveMan · Form 4
Venkatesan Jay insider trades
> Search tickers & screens ⌘K
LIVE

Venkatesan Jay insider trades

Venkatesan Jay has filed 22 Form 4s with the SEC that we hold, for Elicio Therapeutics, Inc. (ELTX) (Director), Serina Therapeutics, Inc. (SER) (Director) and ALPN (Director, 10% owner). Across all of them we count 10 purchases worth $1.1M and 2 sales worth $6.3M reported on Form 4. In the last 12 months: 1 purchase ($1.0K) and 0 sales ($0). The largest single trade was a sale of 400,000 shares of ALPN worth $3.8M, dated 2021-09-17. The first filing on our record is dated 2021-09-21 and the latest 2026-09-02.

Elicio Therapeutics, Inc. (ELTX)

Director · 14 filings · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-02-09S, sale reported on Form 4159,177$2.5M2022-05-27
2021-12-15P, purchase reported on Form 477,604$187.0K2021-12-17
2021-12-16P, purchase reported on Form 427,883$71.1K2021-12-20
2021-12-17P, purchase reported on Form 413,742$34.9K2021-12-20
2021-12-20P, purchase reported on Form 43,527$9.0K2021-12-22
2021-12-27P, purchase reported on Form 466,907$170.6K2021-12-29
2021-12-28P, purchase reported on Form 4210,337$559.5K2021-12-29
2022-05-20P, purchase reported on Form 450,000$61.5K2022-05-25
2022-05-24P, purchase reported on Form 432,200$39.9K2022-05-25
2022-05-25P, purchase reported on Form 411,313$14.1K2022-05-27

Serina Therapeutics, Inc. (SER)

Director · 5 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-05-22P, purchase reported on Form 4589$1.0K2026-06-22

ALPN

Director, 10% owner · 3 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-09-17S, sale reported on Form 4400,000$3.8M2021-09-21
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1413350) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms